StockNews.com began coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a research report report published on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other brokerages have also recently commented on NSTG. Morgan Stanley cut their price target on shares of NanoString Technologies from $14.00 […]